Stock Comparison

ABBV vs VMD

AbbVie Inc vs Viemed Healthcare Inc

The Verdict

VMD takes this one.

ABBV

AbbVie Inc

0.1

out of 10

Distressed

Winner

VMD

Viemed Healthcare Inc

9.1

out of 10

Hidden Gem

Head-to-Head

$381.1B

Market Cap

$358M

104.8

P/E Ratio

24.1

5.8%

Profit Margin

5.2%

95.6%

Return on Equity

10.7%

20.2

Debt-to-Equity

0.1

Moderate

Overall Risk

Moderate

0.1

DVR Score

9.1

The Deep Dive

ABBV0.1/10

AbbVie (ABBV) remains a well-established mega-cap pharmaceutical company, demonstrating stable, incremental growth driven by its robust immunology portfolio, notably Skyrizi and Rinvoq. Q1 2026 results showed modest revenue and adjusted EPS growth, with slightly raised full-year guidance. While financially healthy and a strong dividend payer, its immense market capitalization ($381.10B) and the ma...

Full ABBV Analysis

VMD9.1/10

Viemed Healthcare Inc. continues to exhibit strong performance and strategic execution within the high-growth tech-enabled home respiratory and chronic care market. Q1 2026 results show impressive 28% YoY revenue growth and an improved gross margin. The company has no net debt and generates substantial, growing free cash flow ($36.3M TTM), supporting its active share repurchase program. Management...

Full VMD Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.